Innovation and Challenges in Male Contraception

The unwanted cases of pregnancy have increased resulting in improper family planning and cases of depression or stillbirth. The decision regarding reproduction is shared equivalently by men and women. Although the contraception methods result in effectiveness, they have more complications than effective results. Hormonal disbalance and endometriosis are a few such examples. Contraception for males is limited, yet has more effective results and fewer complications. The development of male contraception is vastly researched over the past few decades. Various hormonal and non-hormonal methods are being developed to provide better contraception with minimum or no disadvantage. The basic advantage of developing a male contraceptive includes its availability, low cost, no side effects, and ease of use.

[1]  N. K. Lohiya,et al.  RISUG® as a male contraceptive: journey from bench to bedside , 2020, Basic and Clinical Andrology.

[2]  J. Amory.  Development of Novel Male Contraceptives , 2019, Clinical and translational science.

[3]  S. Page,et al.  Recent Developments in Male Contraception , 2018, Drugs.

[4]  T. Dhali,et al.  The Condom , 2018, Sexuality & Culture.

[5]  J. Zillioux,et al.  The future of male contraception: a fertile ground , 2018, Translational andrology and urology.

[6]  Manas Ranjan Pradhan,et al.  The incidence of abortion and unintended pregnancy in India, 2015 , 2018, The Lancet. Global health.

[7]  Olivia Plana,et al.  Male Contraception: Research, New Methods, and Implications for Marginalized Populations , 2017, American journal of men's health.

[8]  C. Premanandan,et al.  Reversibility of Vasalgel™ male contraceptive in a rabbit model , 2017, Basic and Clinical Andrology.

[9]  C. Vandevoort,et al.  The contraceptive efficacy of intravas injection of Vasalgel™ for adult male rhesus monkeys , 2017, Basic and Clinical Andrology.

[10]  J. Higgins,et al.  The Sexual Acceptability of Contraception: Reviewing the Literature and Building a New Concept , 2016, Journal of sex research.

[11]  L. Verwey.  Hydrogels based on poly(styrene-co-maleic anhydride) for the application of reversible male contraceptive , 2016 .

[12]  Abhishek P Patel,et al.  Vasectomy reversal: a clinical update , 2016, Asian journal of andrology.

[13]  R. Swerdloff,et al.  Male Hormonal Contraception: Where Are We Now? , 2016, Current Obstetrics and Gynecology Reports.

[14]  C. Payne,et al.  Male contraception: past, present and future. , 2015, Current molecular pharmacology.

[15]  Costantino Antonietta,et al.  Advances in male hormonal contraception , 2014, The Indian Journal of Medical Research.

[16]  D. Archer,et al.  Ethinyl estradiol and 17β-estradiol in combined oral contraceptives: pharmacokinetics, pharmacodynamics and risk assessment. , 2013, Contraception.

[17]  R. Swerdloff,et al.  Hormonal approaches to male contraception , 2010, Current opinion in urology.

[18]  Pradeep K. Jha,et al.  Smart RISUG: A potential new contraceptive and its magnetic field-mediated sperm interaction , 2009, International journal of nanomedicine.

[19]  I. Mavranezouli,et al.  Unintended pregnancy in sub-Saharan Africa: magnitude of the problem and potential role of contraceptive implants to alleviate it. , 2008, Contraception.

[20]  W. Bremner,et al.  Advances in male contraception. , 2008, Endocrine reviews.

[21]  L. Howe.  Surgical methods of contraception and sterilization. , 2006, Theriogenology.

[22]  H. Behre,et al.  Testosterone replacement therapy: current trends and future directions. , 2004, Human reproduction update.

[23]  G. Benagiano,et al.  Clinical profile of contraceptive progestins , 2004, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

[24]  E. Nieschlag,et al.  A clinical trial of 7 alpha-methyl-19-nortestosterone implants for possible use as a long-acting contraceptive for men. , 2003, The Journal of clinical endocrinology and metabolism.

[25]  W. Bremner,et al.  Regulation of testicular function in men: implications for male hormonal contraceptive development , 2003, The Journal of Steroid Biochemistry and Molecular Biology.

[26]  Brigitte L. Sicat.  Ortho Evra, a New Contraceptive Patch , 2003, Pharmacotherapy.

[27]  E. Coutinho,et al.  Gossypol: a contraceptive for men. , 2002, Contraception.

[28]  J. Longworth,et al.  Recent advances in barrier contraception: review and report of clinical trial of the Oves cervical cap. , 2001 .

[29]  W. Bremner,et al.  Low dose of cyproterone acetate and testosterone enanthate for contraception in men. , 1998, Human reproduction.

[30]  R. Lobo,et al.  New knowledge in the physiology of hormonal contraceptives , 1994 .

[31]  A. Faúndes,et al.  Effectiveness of the diaphragm, used continuously, without spermicide. , 1993, Contraception.

[32]  F. Speizer,et al.  A long-term study of mortality in men who have undergone vasectomy. , 1992, The New England journal of medicine.

[33]  G. Mastorakos,et al.  Combined oral contraceptives: Why, when, where? , 2022, Polycystic Ovary Syndrome.

[34]  V. Mathew,et al.  Male contraception , 2012, Indian journal of endocrinology and metabolism.

[35]  S. Schnare.  Progestin contraceptives. , 2002, Journal of midwifery & women's health.

[36]  E. Coutinho,et al.  Gossypol blood levels and inhibition of spermatogenesis in men taking gossypol as a contraceptive. A multicenter, international, dose-finding study. , 2000, Contraception.

[37]  I. Virjo,et al.  Contraceptive methods used and preferred by men and women , 1999, Advances in contraception : the official journal of the Society for the Advancement of Contraception.

[38]  M. M. M. John K. Amory,et al.  Male contraception , 1987 .